Octenisept (Octenidine Dihydrochloride, Phenoxyethanol)

Octenidine dihydrochloride is a bis‑biguanide that binds to bacterial cell membranes, disrupting their integrity and causing leakage of intracellular contents, which leads to rapid cell death. Phenoxyethanol complements this action by denaturing proteins and further compromising membrane function, providing a broad‑spectrum antimicrobial effect against Gram‑positive and Gram‑negative bacteria, as well as some fungi and viruses.

The dosage of Octenisept is determined by the prescribing healthcare professional based on the specific indication, the size of the area to be treated, and patient factors. Typically, a small amount of the solution is applied to the target skin or mucosal surface using a sterile swab or gauze, and the treated area may be re‑treated as directed by the clinician.

Safety data for Octenisept in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Consequently, it should only be used during pregnancy or while breastfeeding if the potential benefit justifies any potential risk to the fetus or infant, and this decision should be made by a qualified healthcare provider.

To order Octenisept, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide; after receiving the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any temperature control if needed) and assist with import documentation.

Both Octenisept and chlorhexidine are broad‑spectrum antiseptics used for skin preparation, but Octenisept combines octenidine dihydrochloride with phenoxyethanol, offering rapid bactericidal activity and a lower risk of resistance development. Chlorhexidine has a longer residual effect but may cause more irritation in some patients. Choice between them depends on clinical protocol, patient tolerance and institutional preference.

Octenisept should be stored at room temperature, preferably below 25 °C, in its original container protected from direct sunlight and moisture. The bottle should be tightly closed when not in use to prevent evaporation. Keep out of reach of children and avoid freezing, as extreme temperatures may affect the stability of the active ingredients.

Octenisept is applied topically to the skin or mucous membranes. A sterile swab, gauze pad, or spray can be used to spread a thin layer of the solution over the target area, ensuring full coverage. The product is typically left to air‑dry; no rinsing is required unless directed by a clinician. Administration is performed by trained healthcare personnel or, for minor uses, by patients following instructions.

Although generally well tolerated, Octenisept can cause serious adverse reactions in rare cases. These include severe allergic reactions such as anaphylaxis, extensive skin necrosis, and systemic toxicity if large amounts are absorbed. Immediate medical attention is required if signs of a severe reaction, such as difficulty breathing, swelling of the face or throat, or widespread skin damage, occur after application.

Octenisept should not be used on patients with known hypersensitivity to octenidine, phenoxyethanol, or any component of the formulation. It is also contraindicated on deep puncture wounds, extensive burns, or mucosal surfaces where irritation could be severe, unless specifically directed by a clinician. Children and immunocompromised individuals should use the product only under medical supervision.